Cargando…
Zinc oxide nanoparticles (ZnO NPs) combined with cisplatin and gemcitabine inhibits tumor activity of NSCLC cells
Non-small cell lung cancer (NSCLC) is one of the most common malignancies worldwide. The use of a combination of chemotherapy drugs and zinc oxide nanoparticles (ZnO-NPs), which have proven to induce tumor-selective cell death, reduce the drug resistance and reduce the side effects in vitro. In the...
Autores principales: | Hu, Chenping, Du, Wenxiu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803530/ https://www.ncbi.nlm.nih.gov/pubmed/33232271 http://dx.doi.org/10.18632/aging.104187 |
Ejemplares similares
-
Exploring the Journey of Zinc Oxide Nanoparticles (ZnO-NPs) toward Biomedical Applications
por: Islam, Fahadul, et al.
Publicado: (2022) -
Molecular Mechanisms of Zinc Oxide Nanoparticle-Induced Genotoxicity Short Running Title: Genotoxicity of ZnO NPs
por: Scherzad, Agmal, et al.
Publicado: (2017) -
Recent Advances in Zinc Oxide Nanoparticles (ZnO NPs) for Cancer Diagnosis, Target Drug Delivery, and Treatment
por: Anjum, Sumaira, et al.
Publicado: (2021) -
Optical, morphological and biological analysis of zinc oxide nanoparticles (ZnO NPs) using Papaver somniferum L.
por: Muhammad, Wali, et al.
Publicado: (2019) -
Salinity Moderated the Toxicity of Zinc Oxide Nanoparticles (ZnO NPs) towards the Early Development of Takifugu obscurus
por: Lin, Yuqing, et al.
Publicado: (2023)